NasdaqGS - Delayed Quote USD

PepGen Inc. (PEPG)

1.4900
-0.0500
(-3.25%)
At close: May 19 at 4:00:01 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
109,262
97,739
84,766
68,301
27,109
Operating Income
-109,262
-97,739
-84,766
-68,301
-27,109
Net Non Operating Interest Income Expense
6,529
7,142
6,400
2,793
0
Other Income Expense
-47
-1
-187
110
-172
Pretax Income
-102,780
-90,598
-78,553
-65,398
-27,281
Tax Provision
-617
-617
73
3,706
0
Net Income Common Stockholders
-102,163
-89,981
-78,626
-69,104
-27,281
Diluted NI Available to Com Stockholders
-102,163
-89,981
-78,626
-69,104
-27,281
Basic EPS
-3.14
--
-3.30
-2.91
-3.53
Diluted EPS
-3.14
--
-3.30
-2.91
-3.53
Basic Average Shares
32,587.6530
--
23,796
23,713.1960
7,717.6180
Diluted Average Shares
32,587.6530
--
23,796
23,713.1960
7,717.6180
Total Operating Income as Reported
-109,262
-97,739
-84,766
-68,301
-27,109
Total Expenses
109,262
97,739
84,766
68,301
27,109
Net Income from Continuing & Discontinued Operation
-102,163
-89,981
-78,626
-69,104
-27,281
Normalized Income
-102,163
-89,981
-78,626
-69,104
-27,281
Interest Income
6,529
7,142
6,400
2,793
0
Net Interest Income
6,529
7,142
6,400
2,793
0
EBIT
-109,262
-97,739
-84,766
-68,301
-27,109
EBITDA
-102,925
-92,486
-83,916
-67,808
-26,931
Reconciled Depreciation
6,337
5,253
850
493
178
Net Income from Continuing Operation Net Minority Interest
-102,163
-89,981
-78,626
-69,104
-27,281
Normalized EBITDA
-102,925
-92,486
-83,916
-67,808
-26,931
Tax Rate for Calcs
0
0
0.0002
0.0002
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 5/6/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

DSGN Design Therapeutics, Inc.
3.5300
+0.57%
 
GLUE Monte Rosa Therapeutics, Inc.
4.1100
+3.27%
 
CGEM Cullinan Therapeutics, Inc.
7.71
+2.80%
 
RLYB Rallybio Corporation
0.3470
-0.86%
 
ACRV Acrivon Therapeutics, Inc.
1.1800
+2.61%
 
ENVB Enveric Biosciences, Inc.
1.3600
+4.62%
 
TYRA Tyra Biosciences, Inc.
9.68
-3.10%
 
MLYS Mineralys Therapeutics, Inc.
15.32
-0.20%
 
HLVX HilleVax, Inc.
1.9500
-1.02%
 
EWTX Edgewise Therapeutics, Inc.
14.79
+0.07%